Efficacy of a Combination of Tanacetum parthenium, 5-Hydroxy Tryptophan and Magnesium (Aurastop) in the Prevention of High Frequency Migraine with Aura
Volta, G. D. , Zavarise, P. , Perego, L. and Pezzini, A. (2018). Efficacy of a Combination of Tanacetum parthenium, 5-Hydroxy Tryptophan and Magnesium (Aurastop) in the Prevention of High Frequency Migraine with Aura. Open Access Library Journal, 5, e4939. doi: http://dx.doi.org/10.4236/oalib.1104939.
GBD 2015 Neurological Disorder Collaborator Group (2017) Global, Regional and National Burden of Neurological Disorders during 1990-2015; A Systematic Analysis for the Global Burden of Disease Study 2015. Lancet Neurology, 16, 877-897.
Lipton, R.B., Bigal, M.E., Diamond, M., et al. (2007) Migraine Prevalence, Disease Burden, and the Need for Preventive Therapy. Neurology, 68, 343-349. https://doi.org/10.1212/01.wnl.0000252808.97649.21
D’Andrea, G., Granella, F., Cadaldini, M. and Manzoni, G.C. (1999) Effectiveness of Lamotrigine in the Prophylaxis of Migraine with Aura: An Open Pilot Study. Cephalalgia, 19, 64-66. https://doi.org/10.1111/j.1468-2982.1999.1901064.x
Lampl, C., Buzath, A., Klinger, D. and Neumann, K. (1999) Lamotrigine in the Prophylactic Treatment of Migraine Aura—A Pilot Study. Cephalalgia, 19, 58-63 157.
Pascual, J., Caminero, A.B., Mateos, V., Roig, C., Leira, R., Garci’aMonco, C. and Lai’nez, M.J. (2004) Preventing Disturbing Migraine Aura with Lamotrigine: An Open Study. Headache, 44, 1024-1028.
https://doi.org/10.1111/j.1526-4610.2004.04198.x
Pittler, M.H. and Ernst, E. (2000) Feverfew for Preventing Migraine. Cochrane Database of Systematic Reviews, No. 1, CD002286. https://doi.org/10.1002/14651858.CD002286
Rajapakse, T., et al. (2016) Nutraceuticals in Migraine: A Summary of Existing Guidelines for Use. Headache, 56, 808-816. https://doi.org/10.1111/head.12789
Zavarise, P. and Dalla Volta, G. (2017) A Combination of Tanacetum parthenium, Griffonia simplicifolia and Magnesium (Aurastop) as Symptomatic Acute Treat-ment for Migraine Aura: A Retrospective Cohort Study. Open Access Library Journal, 4, e3660.
Merlo, P., Maggioni, F., Zanchin, G., et al. (2017) Efficacy in Episodic Migraine Prevention of a Combination of Tanacethum p Arthenium, 5-Hydroxy Tryptophan and Magnesium (Aurastop). A Multicentric Observational Study. Journal of Headache and Pain, 18, 202.
Zavarize, P., Pezzini, A. and Dalla Volta, G. (2017) Combination of Tanacethum p Artenium, 5-Hydrossitriptophan (5-Http) and Magnesium in the Prophylaxis of Episodic Migraine without Aura (AURASTOP) An Observational Study. International Journal of Neurology and Brain Disorders, 4, 1-4.
https://doi.org/10.15436/2377-1348.17.1630
Csáti, A., Edvinsson, L., Vécsei, L., Toldi, J., Füloi, J. and Warfvinge, K. (2015) Kynurenic Acid Modulates Experimentally Induced Inflammation in the Trigeminal Ganglion. Journal of Headache and Pain, 16, 99.
https://doi.org/10.1186/s10194-015-0581-x
Chauvel, V., et al. (2012) Effect of Systemic Kynurenine on Cortical Spreading Depression and Its Modulation by Sex Hormones in Rat. Experimental Neurology, 236, 207-214. https://doi.org/10.1016/j.expneurol.2012.05.002
Olàh, G., Herédi, J., Menyhàrt, A., Czinege, Z., Nagy, D., Fuzik, J., Kocsis, K., Knapp, L., Krucsò, E., Gellért, L., Kis, Z., Farkas, T., Fulop, F., Pàrdutz, A., Tajti, J., Vécsei, L. and Toldi, J. (2013) Unexpected Effects of Peripherally Administered Kynurenic Acid on Cortical Spreading Depression and Related Blood-Brain Barrier Permeability. Drug Design, Development and Therapy, 16, 981-987
Curto, M., Lionetto, L., Negro, A., Capi, M., Fazio, F., Giamberardino, M.A., et al. (2015) Altered Kynurenine Pathway Metabolites in Serum of Chronic Migraine Patients. The Journal of Headache and Pain, 17, 47. https://doi.org/10.1186/s10194-016-0638-5
Tassorelli, C., et al. (2005) Parthenolide Is the Component of Tanacetum Parthenium That Inhibits Nitroglycerin-Induced Fos Activation: Studies in an Animal Model of Migraine. Cephalalgia, 25, 612-621. https://doi.org/10.1111/j.1468-2982.2005.00915.x
Materazzi, S., Benemei, S., Fusi, C., et al. (2013) Parthenolide Inhibits Nociception and Neurogenic Vasodilatation in the Trigeminovascular System by Targeting the TRPA1 Channel. Pain, 154, 2750-2758. https://doi.org/10.1016/j.pain.2013.08.002
Sun-Edelstein, C. and Mauskop, A. (2009) Role of Magnesium in the Pathogenesis and Treatment of Migraine. Expert Review of Neurotherapeutics, 9, 369-379. https://doi.org/10.1586/14737175.9.3.369
Mody, I., Lambert, J.D. and Heinemann, U. (1987) Low Extracellular Magnesium Induces Epileptiform Activity and Spreading Depression in Rat Hippocampal Slices. Journal of Neurophysiology, 57, 869-888. https://doi.org/10.1152/jn.1987.57.3.869